Atorvastatin and simvastatin in clinical management of high-risk patients

Aim. То assess the use of average therapeutic doses of atorvastatin and simvastatin (Torvacard and Simvacard) in real-world clinical management of high-risk patients.Material and methods. The study included 347 doctors from 30 Russian cities and 1163 high-risk patients randomised into two groups: To...

Full description

Bibliographic Details
Main Authors: S. A. Shalnova, A. D. Deev
Format: Article
Language:Russian
Published: «SILICEA-POLIGRAF» LLC 2009-02-01
Series:Кардиоваскулярная терапия и профилактика
Subjects:
Online Access:https://cardiovascular.elpub.ru/jour/article/view/1152